Product Information

VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.1911 per EA under NDC 62332008271. Its NADAC has been published 528 times since Jul 13, 2016.

FDA first approved this application on Mar 21, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB

Valsartan and Hydrochlorothiazide
$0.1911per EA

Strength

12.5; 320 mg/1; mg/1

NDC

62332008271

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA201662

FDA Approved

3/21/2013

TE Code

AB

On Market Since

5/20/2016

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB has been published 528 times since Jul 13, 2016, and over the history we have for it it has declined 41.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1911 per EA
All-time high$0.7070 (Dec 16, 2020)
All-time low$0.1878 (Jul 22, 2026)
52-week high$0.2307
52-week low$0.1878
Median price$0.2765
Average price$0.3296
Largest weekly change+57.9% (Jan 22, 2020)
Weeks tracked528
Tracking sinceJul 13, 2016

Price History

1W

+1.8%

1M

+1.8%

3M

-3.5%

6M

-10.2%

1Y

-17.1%

3Y

-38.8%

5Y

-64.8%

All

-41.6%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB, manufactured by Alembic Pharmaceuticals Inc., is $0.1911 per EA (NDC 62332008271), effective Aug 19, 2026.

How has the price of VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB has declined 41.6%. It has been tracked across 528 weekly CMS publications since Jul 13, 2016.

What are the highest and lowest recorded NADAC prices for VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB?

Since Jul 13, 2016, the NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB has ranged from a low of $0.1878 (Jul 22, 2026) to a high of $0.7070 (Dec 16, 2020), with a median of $0.2765 per EA.

Are there cheaper alternatives to VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB?

VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB (NDC 62332008271) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.